1986
DOI: 10.1016/0360-3016(86)90388-3
|View full text |Cite
|
Sign up to set email alerts
|

Clinical study of the radioprotective effects of amifostine (YM-08310, WR-2721) on chronic radiation injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
16
0
2

Year Published

1987
1987
2017
2017

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 59 publications
(18 citation statements)
references
References 2 publications
0
16
0
2
Order By: Relevance
“…Morphological and physiological studies have identified the renal tubule system as the site of maximum radiation damage [3,6,10,11,14,28,[31][32][33]. According to the results of our study, tubular toxicity induced by 6-Gy irradiation was seen over a period of 6 months.…”
Section: Discussionmentioning
confidence: 54%
See 2 more Smart Citations
“…Morphological and physiological studies have identified the renal tubule system as the site of maximum radiation damage [3,6,10,11,14,28,[31][32][33]. According to the results of our study, tubular toxicity induced by 6-Gy irradiation was seen over a period of 6 months.…”
Section: Discussionmentioning
confidence: 54%
“…The protective effect of amifostine against ionizing radiation has already been shown on salivary glands, bone marrow and lungs using scintigraphic methods [2,4,28,30]. However, to the best of our knowledge, there is no published data in the literature presenting a protective effect of amifostine on renal parenchymal tissue against ionizing radiation via static or dynamic renal scintigraphy.…”
Section: Discussionmentioning
confidence: 96%
See 1 more Smart Citation
“…Considerable interest has recently been expressed in the use of phosphorylthioate drugs as adjuvants to radiotherapy (Kligerman et al, 1980(Kligerman et al, , 1984Takahasi et al, 1986). This interest is based upon an early observation by Yuhas and Storer, (1969) that WR-2721 differentially protects normal as compared to tumour cells.…”
mentioning
confidence: 99%
“…Histologische Untersuchungen am Kaninchen bestäti-gen dies, eine Lipomatose der Speicheldrüse tritt unter Amifostinschutz nicht auf [4]. Strnad et al [24] [1,6,9,19,20] konnten ebenfalls zeigen, dass Amifostin unter den Bedingungen einer Radiochemotherapie zu einer verminderten Mukositis und Xerostomie führt.…”
Section: Radioprotektive Wirkung Von Amifostinunclassified